This is unpublished

Cameron J.

he, him, his
Physician & Research Faculty
Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
Professor, Division of Medical Oncology, University of Washington
Anderson Family Endowed Chair for Immunotherapy, Fred Hutch
Sites of Practice
Seattle Cancer Care Alliance

Photo: Fred Hutch

Education, Training, Board Certifications 

  • M.B.B.S., The University of Sydney, Australia
  • Ph.D., The University of Queensland, Australia 
  • Residency, University of Sydney, Australia 
  • F.R.A.C.P., Fellow of the Royal Australasian College of Physicians
  • F.R.C.P.A., Fellow of the Royal College of Pathologists of Australasia

Clinical Expertise

  • T cell immunotherapy for hematologic malignancies 
  • Hematopoietic stem cell transplantation 
  • Hematologic malignancies



Research and/or clinical interests 

Dr. Cameron Turtle studies how immune T cells can be engineered to fight hematologic malignancies, such as non-Hodgkin lymphoma, acute lymphoblastic leukemia, chronic lymphocytic leukemia and acute myeloid leukemia. He serves as an attending physician on the Hematopoietic Cell Transplant Service and the Immunotherapy Service at Seattle Cancer Care Alliance and the UW Medical Center. His laboratory in the Clinical Research Division at Fred Hutch is focused on understanding the characteristics of distinct subsets of human CD8+ T cells, their potential utility for tumor immunotherapy, and their role in immune reconstitution after blood stem cell transplantation.

Dr. Turtle’s lab has extensive expertise in conducting investigator-initiated clinical trials of T-cell immunotherapies for patients with B-cell malignancies. The lab conducts detailed studies of the reasons for success and failure of T cell therapies in treated patients, enabling a rational approach to improving treatment of patients with cancer.